Rodrick S. Katete
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rodrick S. Katete has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Bernard Mudenda Hang’ombe
University of Zambia
1 shared publication - Cephas Sialubanje
Lvey Mwanawasa Medical University, School of Public Health, Lusala, Zambia
1 shared publication - Chie Nakajima
Division of Bioresources, Hokkaido University International Institute for Zoonosis Control
1 shared publication Emmanuel Zulu
Institute of Basic and Biomedical Sciences, Levy Mwanawasa Medical University, Lusaka, Zambia
1 shared publicationFreeman W. Chabala
Institute of Basic and Biomedical Sciences, Levy Mwanawasa Medical University, Lusaka, Zambia
1 shared publication- Freeman W. Chabala
The Institute of Basic and Biomedical Sciences Levy Mwanawasa Medical University Lusaka Zambia
1 shared publication
Latest Publications
- Open Access
Antimicrobial Resistance Patterns and Serological Diversity of Shigella Species from Patient Isolates at University Teaching Hospital in Lusaka, Zambia
Background: Shigella species are the leading cause of human shigellosis. In Zambia, more than 30% of children experiencing diarrhea are infected with Shigella species. The increasing resistance of Shigella species to the recommended therapy is of great concern. Therefore, this study investigated the antibiotic resistance profiles and phenotypic and genotypic characteristics of Shigella isolates at the largest referral hospital in Zambia. Methodology: Of the forty-eight archived presumptive Shigella isolates, thirty-two were serologically confirmed and subjected to antimicrobial susceptibility testing using the Kirby Bauer disk diffusion method. Thereafter, polymerase chain reaction was performed to detect the bla genes. Results: Most isolates were Shigella flexneri (16/32, 50%) and Shigella sonnei (14/32, 44%), while Shigella boydii and Shigella dysenteriae were rare. High resistance rates were noted for sulfamethoxazole/trimethoprim (78%) and tetracycline (75%), while 15.6% of the isolates showed resistance to ciprofloxacin and/or azithromycin. The blaTEM gene encoding beta-lactamase was detected in 7/32 (22%) of isolates. Conclusions: In this study, a significant number of multidrug-resistant isolates were identified. Additionally, Shigella species resistant to the World Health Organization-recommended drugs call for strengthened laboratory diagnosis and close monitoring of these pathogens to guide the clinical management of shigellosis.
Open AccessAntimicrobial Resistance Patterns and Serological Diversity of Shigella Species from Patient Isolates at University Teaching Hospital in Lusaka, Zambia
Background: Shigella species are the leading cause of human shigellosis. In Zambia, more than 30% of children experiencing diarrhea are infected with Shigella species. The increasing resistance of Shigella species to the recommended therapy is of great concern. Therefore, this study investigated the antibiotic resistance profiles and phenotypic and genotypic characteristics of Shigella isolates at the largest referral hospital in Zambia. Methodology: Of the forty-eight archived presumptive Shigella isolates, thirty-two were serologically confirmed and subjected to antimicrobial susceptibility testing using the Kirby Bauer disk diffusion method. Thereafter, polymerase chain reaction was performed to detect the bla genes. Results: Most isolates were Shigella flexneri (16/32, 50%) and Shigella sonnei (14/32, 44%), while Shigella boydii and Shigella dysenteriae were rare. High resistance rates were noted for sulfamethoxazole/trimethoprim (78%) and tetracycline (75%), while 15.6% of the isolates showed resistance to ciprofloxacin and/or azithromycin. The blaTEM gene encoding beta-lactamase was detected in 7/32 (22%) of isolates. Conclusions: In this study, a significant number of multidrug-resistant isolates were identified. Additionally, Shigella species resistant to the World Health Organization-recommended drugs call for strengthened laboratory diagnosis and close monitoring of these pathogens to guide the clinical management of shigellosis.
- Open Access
- 9 September 2023
- Published by Egyptian Knowledge Bank in Microbes and Infectious Diseases
Characterization of SARS-CoV-2 genetic diversity in Zambia: Single center study
Background: The emergency of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) variants has led to COVID-19 worldwide with substantial social and economic consequences. SARS CoV-2 S-glycoproteins are involved in viral entry to human cells. They are naturally the main target of host immune responses, and most vaccine designs are based on them. SARS-CoV-2 variants are categorized as variants of interest (VOI) or variants of concern (VOC) because they are deadly and highly transmissible, causing illness by overcoming the host immune system. Material and Methods: The COVID-19 patients’ samples were isolated for genome sequencing to identify the mutations that alter the viral genotypic traits. Genome annotation and phylogenetic analysis were performed using MEGA 7.0. Results: Phylogenetic analysis revealed that the omicron variant of concern and sub-variants XBB, XBB.2.6, BQ.1, and BQ.1.1 are the most prevalent variants in Lusaka, Zambia. Analysis of the translated protein sequences in this study revealed D614G mutation in all the sequences. This mutation has previously been implicated in viral transmission, increasing the infectivity, replication efficacy, stability of virions, and virulence in its human host. Conclusion: Analysis of the SARS-CoV-2 genome provided crucial information on the variant and its source as it spreads in Lusaka from person to person. This research has a huge potential in genomic epidemiology, where genomic surveillance is employed to detect new mutations or SARS-CoV-2 variants, which can help the virus to spread rapidly, increase disease severity, or even evade vaccine-induced immunity.
- 9 September 2023
- Published by Egyptian Knowledge Bank in Microbes and Infectious Diseases
Open AccessCharacterization of SARS-CoV-2 genetic diversity in Zambia: Single center study
Background: The emergency of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) variants has led to COVID-19 worldwide with substantial social and economic consequences. SARS CoV-2 S-glycoproteins are involved in viral entry to human cells. They are naturally the main target of host immune responses, and most vaccine designs are based on them. SARS-CoV-2 variants are categorized as variants of interest (VOI) or variants of concern (VOC) because they are deadly and highly transmissible, causing illness by overcoming the host immune system. Material and Methods: The COVID-19 patients’ samples were isolated for genome sequencing to identify the mutations that alter the viral genotypic traits. Genome annotation and phylogenetic analysis were performed using MEGA 7.0. Results: Phylogenetic analysis revealed that the omicron variant of concern and sub-variants XBB, XBB.2.6, BQ.1, and BQ.1.1 are the most prevalent variants in Lusaka, Zambia. Analysis of the translated protein sequences in this study revealed D614G mutation in all the sequences. This mutation has previously been implicated in viral transmission, increasing the infectivity, replication efficacy, stability of virions, and virulence in its human host. Conclusion: Analysis of the SARS-CoV-2 genome provided crucial information on the variant and its source as it spreads in Lusaka from person to person. This research has a huge potential in genomic epidemiology, where genomic surveillance is employed to detect new mutations or SARS-CoV-2 variants, which can help the virus to spread rapidly, increase disease severity, or even evade vaccine-induced immunity.